Bavarian Nordic AS (CHIX:BAVAC) Moat Score: 5/10 (As of Jun. 30, 2026)


CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
84 GF Score
Price kr188.30
GF Value kr174.21
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Bavarian Nordic AS Moat Score?

Bavarian Nordic AS CHIX:BAVAC 84 Moat Score is 5 as of Jun. 30, 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 84/100 and a GF Value™ of kr174.21 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,401 Biotechnology companies, Bavarian Nordic AS ranks better than 96.72% on this metric.

Bavarian Nordic AS has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Bavarian Nordic AS has Narrow Moat: Bavarian Nordic AS has a solid narrow moat with valuable patents and a strong R&D pipeline in the biotech sector. However, it faces competition and lacks significant market share or customer loyalty, limiting its pricing power and regulatory barriers.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Bavarian Nordic AS might have Narrow Moat - Solid narrow moat.

Bavarian Nordic AS  (CHIX:BAVAc) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Bavarian Nordic AS Moat Score Related Terms

CHIX:BAVAC vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Bavarian Nordic AS's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bavarian Nordic AS Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Moat Score distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Moat Score falls into.


CHIX:BAVAC
84GF Score
Bavarian Nordic AS CHIX:BAVAC
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Bavarian Nordic AS (CHIX:BAVAC) has a Moat Score of 5 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Bavarian Nordic AS ranks #46 out of 1401 companies in the Biotechnology industry, placing it in the top 3.3%.
Is Bavarian Nordic AS's Moat Score too high?
Bavarian Nordic AS's current Moat Score is 5. The Biotechnology industry median Moat Score is 2.00. Bavarian Nordic AS's value of 5 is 150% above this industry median. Based on the distribution chart, Bavarian Nordic AS ranks #46 out of 1401 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bavarian Nordic AS has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bavarian Nordic AS ranks #46 out of 1401 companies for Moat Score. This places Bavarian Nordic AS in the top 3% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Bavarian Nordic AS's value of 5 is 150% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,401 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bavarian Nordic AS's current Moat Score of 5 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bavarian Nordic AS's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Fairly Valued. The stock's GF Value™ is kr174.21, compared to a current price of kr188.30 — trading 8.1% above its estimated fair value. The current Moat Score is 5 and 150% above the Biotechnology industry median of 2.00. Bavarian Nordic AS's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Moat Score is 5 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 8.1% above its estimated GF Value™ of kr174.21. GuruFocus considers Bavarian Nordic AS to be Fairly Valued.

Key valuation signals for CHIX:BAVAC:

  • Moat Score: 5
  • GF Value™: kr174.21 vs. price of kr188.30 (8.1% above fair value)
  • GF Score™: 84/100 with 2 warning signs
  • Industry Position: 150% above the Biotechnology median (#46 of 1401)

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
84GF Score

Get the complete analysis for CHIX:BAVAC

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30
Price
kr174.21
GF Value